SEC Form 4 · accession 0001919170-26-000016
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Coleen Glessner
Officer — EVP, Quality & Ethics, and CPL
Period of report
Jun 8, 2026
Accepted (ET)
Jun 10, 2026 · 3:07 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 8, 2026 | F | 2,018 | $8.00 | D | 202,201 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units.